dr. lancet on cpx-351 in elderly patients with aml
Published 8 years ago • 292 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
2:10
dr. lancet on cpx-351 compared to chemotherapy for older adults with aml
-
1:07
dr. lancet on the function of cpx-351
-
6:26
cpx-351: a potential game-changer for older patients with newly diagnosed secondary aml?
-
8:10
cpx-351: phase iii trial: shown superior 7 3 in older patients with ...
-
4:13
cpx-351: liposomal cytarabine/daunorubicin in secondary aml
-
6:59
cpx-351 for older patients with aml
-
3:09
cpx-351 after stem cell transplant for elderly patients with aml
-
5:19
case 2: cpx-351 treatment for aml with mrc
-
3:21
safety run-in of a phase ii trial of cpx-351 plus pomalidomide in aml with mds-related changes
-
2:44
azacitidine, venetoclax & gilteritinib in older/unfit patients with flt3-mutated aml
-
7:23
are remissions for aml patients 'better' after daunorubicin and cytarabine liposome injection
-
35:36
cpx-351 versus 7 3 cytarabine and daunorubicin chemotherapy in older adults...
-
2:41
lifting limits: liposomal delivery of chemotherapy for secondary aml with cpx-351
-
6:58
outcomes in patients with therapy-related aml who achieved remission with cpx-351 versus 7 plus ...
-
4:16
cpx-351: liposomal daunorubicin/cytarabine for aml
-
8:13
do baseline blast percentages impact survival outcomes with cpx-351 in aml?
-
3:03
cpx-351 vs. hma plus venetoclax in the treatment of patients with aml
-
6:30
jeffrey e. lancet | isal 2019 | the role of cpx 351 in aml
-
6:16
cpx-351 liposome injection vs standard cytarabine and daunorubicin for older high-risk aml patients
-
5:03
combining venetoclax with cpx-351 for aml
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
2:00
aml: toxicities with cpx-351